FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn’s disease through affecting the ADCC activity View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-01-29

AUTHORS

Rintaro Moroi, Katsuya Endo, Yoshitaka Kinouchi, Hisashi Shiga, Yoichi Kakuta, Masatake Kuroha, Yoshitake Kanazawa, Yosuke Shimodaira, Takahiko Horiuchi, Seiichi Takahashi, Tooru Shimosegawa

ABSTRACT

An association between FCGR3A-158 V/F polymorphism and biological responses to infliximab has been reported in Crohn’s disease (CD) in Western countries. However, little is known about the mechanism by which gene polymorphism affects the responses to infliximab. The aims of this study were to confirm the association in Japanese CD patients and to reveal the effect of gene polymorphism on biological responses to infliximab. Japanese CD patients were examined retrospectively at weeks 8 and 30. Clinical and biological responses were assessed by the Crohn’s disease activity index and C-reactive protein levels, respectively. The infliximab-binding affinity of natural killer (NK) cells from FCGR3A-158 V/V, V/F and F/F donors was examined. Infliximab-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) activities were also determined using transmembrane TNF-α-expressing Jurkat T cells as target cells and peripheral blood mononuclear cells (PBMCs) from V/V, V/F and F/F donors as effector cells. Biological responses at week 8 were statistically higher in V/V patients, whereas no significant differences were observed in either clinical responses at weeks 8 and 30 or biological responses at week 30 among the three genotypes. NK cells and PBMCs from V/V patients also showed higher infliximab-binding affinity and infliximab-mediated ADCC activity, respectively. Our results suggest that FCGR3A-158 polymorphism is a predicting factor of biological responses to infliximab in the early phases. FCGR3A-158 polymorphism was also found to affect the infliximab-binding affinity of NK cells and infliximab-mediated ADCC activity in vitro, suggesting that an effect on ADCC activity influences biological responses to infliximab in CD patients. More... »

PAGES

265-271

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00251-013-0679-8

DOI

http://dx.doi.org/10.1007/s00251-013-0679-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041475862

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23358932


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Inflammatory Agents, Non-Steroidal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibody-Dependent Cell Cytotoxicity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "C-Reactive Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Codon", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Crohn Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infliximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Killer Cells, Natural", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukocytes, Mononuclear", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymorphism, Single Nucleotide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, IgG", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "1-1, Seiryo, Aoba-ku, Sendai, Miyagi, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan", 
            "1-1, Seiryo, Aoba-ku, Sendai, Miyagi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moroi", 
        "givenName": "Rintaro", 
        "id": "sg:person.01031346114.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031346114.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Endo", 
        "givenName": "Katsuya", 
        "id": "sg:person.013547252522.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013547252522.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kinouchi", 
        "givenName": "Yoshitaka", 
        "id": "sg:person.01145574514.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145574514.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shiga", 
        "givenName": "Hisashi", 
        "id": "sg:person.01213707714.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213707714.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kakuta", 
        "givenName": "Yoichi", 
        "id": "sg:person.012611662635.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012611662635.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuroha", 
        "givenName": "Masatake", 
        "id": "sg:person.01001764110.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001764110.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kanazawa", 
        "givenName": "Yoshitake", 
        "id": "sg:person.0604532214.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604532214.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shimodaira", 
        "givenName": "Yosuke", 
        "id": "sg:person.0731431552.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731431552.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Kyushu, Japan", 
          "id": "http://www.grid.ac/institutes/grid.177174.3", 
          "name": [
            "Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Kyushu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Horiuchi", 
        "givenName": "Takahiko", 
        "id": "sg:person.01256304453.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256304453.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takahashi", 
        "givenName": "Seiichi", 
        "id": "sg:person.01304671035.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304671035.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shimosegawa", 
        "givenName": "Tooru", 
        "id": "sg:person.01255535707.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255535707.76"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/74704", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000366392", 
          "https://doi.org/10.1038/74704"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-01-29", 
    "datePublishedReg": "2013-01-29", 
    "description": "An association between FCGR3A-158\u00a0V/F polymorphism and biological responses to infliximab has been reported in Crohn\u2019s disease (CD) in Western countries. However, little is known about the mechanism by which gene polymorphism affects the responses to infliximab. The aims of this study were to confirm the association in Japanese CD patients and to reveal the effect of gene polymorphism on biological responses to infliximab. Japanese CD patients were examined retrospectively at weeks 8 and 30. Clinical and biological responses were assessed by the Crohn\u2019s disease activity index and C-reactive protein levels, respectively. The infliximab-binding affinity of natural killer (NK) cells from FCGR3A-158\u00a0V/V, V/F and F/F donors was examined. Infliximab-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) activities were also determined using transmembrane TNF-\u03b1-expressing Jurkat T cells as target cells and peripheral blood mononuclear cells (PBMCs) from V/V, V/F and F/F donors as effector cells. Biological responses at week 8 were statistically higher in V/V patients, whereas no significant differences were observed in either clinical responses at weeks 8 and 30 or biological responses at week 30 among the three genotypes. NK cells and PBMCs from V/V patients also showed higher infliximab-binding affinity and infliximab-mediated ADCC activity, respectively. Our results suggest that FCGR3A-158 polymorphism is a predicting factor of biological responses to infliximab in the early phases. FCGR3A-158 polymorphism was also found to affect the infliximab-binding affinity of NK cells and infliximab-mediated ADCC activity in vitro, suggesting that an effect on ADCC activity influences biological responses to infliximab in CD patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00251-013-0679-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6075693", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1019755", 
        "issn": [
          "0093-7711", 
          "1432-1211"
        ], 
        "name": "Immunogenetics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "65"
      }
    ], 
    "keywords": [
      "peripheral blood mononuclear cells", 
      "disease activity index", 
      "ADCC activity", 
      "CD patients", 
      "Crohn's disease", 
      "week 8", 
      "Japanese CD patients", 
      "NK cells", 
      "gene polymorphisms", 
      "Crohn's Disease Activity Index", 
      "C-reactive protein levels", 
      "antibody-dependent cell-mediated cytotoxicity (ADCC) activity", 
      "natural killer cells", 
      "blood mononuclear cells", 
      "clinical response", 
      "killer cells", 
      "effector cells", 
      "mononuclear cells", 
      "week 30", 
      "infliximab", 
      "T cells", 
      "patients", 
      "biological responses", 
      "F polymorphism", 
      "transmembrane TNF", 
      "activity index", 
      "disease", 
      "target cells", 
      "protein levels", 
      "Jurkat T cells", 
      "significant differences", 
      "Western countries", 
      "cytotoxicity activity", 
      "early phase", 
      "polymorphism", 
      "cells", 
      "association", 
      "response", 
      "TNF", 
      "activity", 
      "donors", 
      "F donors", 
      "effect", 
      "affinity", 
      "aim", 
      "genotypes", 
      "index", 
      "levels", 
      "factors", 
      "differences", 
      "study", 
      "mechanism", 
      "countries", 
      "results", 
      "phase"
    ], 
    "name": "FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn\u2019s disease through affecting the ADCC activity", 
    "pagination": "265-271", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041475862"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00251-013-0679-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23358932"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00251-013-0679-8", 
      "https://app.dimensions.ai/details/publication/pub.1041475862"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T10:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_605.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00251-013-0679-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00251-013-0679-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00251-013-0679-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00251-013-0679-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00251-013-0679-8'


 

This table displays all metadata directly associated to this object as RDF triples.

272 TRIPLES      22 PREDICATES      100 URIs      91 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00251-013-0679-8 schema:about N1a80ac786f3242679aba5f1a74d68eac
2 N1f5c959e7bb84ea7970ea5a20af0399c
3 N21f98d43cb3d41a19382d6283e181147
4 N27f227aea9ee46dd8a2bc477b59aecdc
5 N2f1a08baf8fe4ba59b5c65efdaf4213a
6 N30b185e3f33748939090dea6685cad8a
7 N661fad3f3cbe44469563ac584a6d6b5e
8 N7651cea78c9b42a8bee20a6a1fcb7f68
9 N76f798b064c2417c8f1330f25dc2b337
10 N80044a1fd448408c9edda0573fb47140
11 N8843ff25658544bc8ee33e974707dfb9
12 Na1d66e63073a4e509b8a9bcce6e3ce2f
13 Nb54dfd2cf0374969bdaab01afa0214dd
14 Nc747106c04584978b978c8ad868fb7f2
15 Ne65c61f86c6b4275a7fe1887501e6045
16 Nf752af49ca8143cea725516b8e6cc57a
17 Nff39ff9872b2432c8079a812b684ba9a
18 Nff42b2d8a7f544f48fb90d999ab1e9a6
19 anzsrc-for:11
20 anzsrc-for:1107
21 schema:author Nb7a6e33336b14aaca649e5097712d714
22 schema:citation sg:pub.10.1038/74704
23 schema:datePublished 2013-01-29
24 schema:datePublishedReg 2013-01-29
25 schema:description An association between FCGR3A-158 V/F polymorphism and biological responses to infliximab has been reported in Crohn’s disease (CD) in Western countries. However, little is known about the mechanism by which gene polymorphism affects the responses to infliximab. The aims of this study were to confirm the association in Japanese CD patients and to reveal the effect of gene polymorphism on biological responses to infliximab. Japanese CD patients were examined retrospectively at weeks 8 and 30. Clinical and biological responses were assessed by the Crohn’s disease activity index and C-reactive protein levels, respectively. The infliximab-binding affinity of natural killer (NK) cells from FCGR3A-158 V/V, V/F and F/F donors was examined. Infliximab-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) activities were also determined using transmembrane TNF-α-expressing Jurkat T cells as target cells and peripheral blood mononuclear cells (PBMCs) from V/V, V/F and F/F donors as effector cells. Biological responses at week 8 were statistically higher in V/V patients, whereas no significant differences were observed in either clinical responses at weeks 8 and 30 or biological responses at week 30 among the three genotypes. NK cells and PBMCs from V/V patients also showed higher infliximab-binding affinity and infliximab-mediated ADCC activity, respectively. Our results suggest that FCGR3A-158 polymorphism is a predicting factor of biological responses to infliximab in the early phases. FCGR3A-158 polymorphism was also found to affect the infliximab-binding affinity of NK cells and infliximab-mediated ADCC activity in vitro, suggesting that an effect on ADCC activity influences biological responses to infliximab in CD patients.
26 schema:genre article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf N1b74ea1cce2840e1b604174e0f397b19
30 Nf0d14dac81754a17abd30add774fd1df
31 sg:journal.1019755
32 schema:keywords ADCC activity
33 C-reactive protein levels
34 CD patients
35 Crohn's Disease Activity Index
36 Crohn's disease
37 F donors
38 F polymorphism
39 Japanese CD patients
40 Jurkat T cells
41 NK cells
42 T cells
43 TNF
44 Western countries
45 activity
46 activity index
47 affinity
48 aim
49 antibody-dependent cell-mediated cytotoxicity (ADCC) activity
50 association
51 biological responses
52 blood mononuclear cells
53 cells
54 clinical response
55 countries
56 cytotoxicity activity
57 differences
58 disease
59 disease activity index
60 donors
61 early phase
62 effect
63 effector cells
64 factors
65 gene polymorphisms
66 genotypes
67 index
68 infliximab
69 killer cells
70 levels
71 mechanism
72 mononuclear cells
73 natural killer cells
74 patients
75 peripheral blood mononuclear cells
76 phase
77 polymorphism
78 protein levels
79 response
80 results
81 significant differences
82 study
83 target cells
84 transmembrane TNF
85 week 30
86 week 8
87 schema:name FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn’s disease through affecting the ADCC activity
88 schema:pagination 265-271
89 schema:productId N2b53f5f96c634289bce684be68a46c95
90 N2bb5b3ce7e454831a0019f0ff88c84b4
91 Nd1757fe53dc445d2a91637d876fa8e6e
92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041475862
93 https://doi.org/10.1007/s00251-013-0679-8
94 schema:sdDatePublished 2022-05-10T10:04
95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
96 schema:sdPublisher N5aadfc7c8b27454eaa88cbdbb006c427
97 schema:url https://doi.org/10.1007/s00251-013-0679-8
98 sgo:license sg:explorer/license/
99 sgo:sdDataset articles
100 rdf:type schema:ScholarlyArticle
101 N1a80ac786f3242679aba5f1a74d68eac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Infliximab
103 rdf:type schema:DefinedTerm
104 N1b74ea1cce2840e1b604174e0f397b19 schema:issueNumber 4
105 rdf:type schema:PublicationIssue
106 N1f5c959e7bb84ea7970ea5a20af0399c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Antibody-Dependent Cell Cytotoxicity
108 rdf:type schema:DefinedTerm
109 N21f98d43cb3d41a19382d6283e181147 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Leukocytes, Mononuclear
111 rdf:type schema:DefinedTerm
112 N22f912c1b41643ca81a5aebc4e5b3131 rdf:first sg:person.01256304453.19
113 rdf:rest N3d795f49d971481fb4a6a313ac179ad9
114 N27f227aea9ee46dd8a2bc477b59aecdc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Humans
116 rdf:type schema:DefinedTerm
117 N2b53f5f96c634289bce684be68a46c95 schema:name dimensions_id
118 schema:value pub.1041475862
119 rdf:type schema:PropertyValue
120 N2bb5b3ce7e454831a0019f0ff88c84b4 schema:name doi
121 schema:value 10.1007/s00251-013-0679-8
122 rdf:type schema:PropertyValue
123 N2f1a08baf8fe4ba59b5c65efdaf4213a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Male
125 rdf:type schema:DefinedTerm
126 N30b185e3f33748939090dea6685cad8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Young Adult
128 rdf:type schema:DefinedTerm
129 N3d795f49d971481fb4a6a313ac179ad9 rdf:first sg:person.01304671035.37
130 rdf:rest N4ac1414f66b543a3874e31ba095bfd6a
131 N4ac1414f66b543a3874e31ba095bfd6a rdf:first sg:person.01255535707.76
132 rdf:rest rdf:nil
133 N5aadfc7c8b27454eaa88cbdbb006c427 schema:name Springer Nature - SN SciGraph project
134 rdf:type schema:Organization
135 N661fad3f3cbe44469563ac584a6d6b5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Treatment Outcome
137 rdf:type schema:DefinedTerm
138 N7651cea78c9b42a8bee20a6a1fcb7f68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Codon
140 rdf:type schema:DefinedTerm
141 N76f798b064c2417c8f1330f25dc2b337 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Killer Cells, Natural
143 rdf:type schema:DefinedTerm
144 N80044a1fd448408c9edda0573fb47140 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Crohn Disease
146 rdf:type schema:DefinedTerm
147 N8617ac9b5d7f47e29b5a45c880695f9f rdf:first sg:person.01001764110.70
148 rdf:rest Nbca9cc45122543188e9c8371aaffc584
149 N8843ff25658544bc8ee33e974707dfb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name C-Reactive Protein
151 rdf:type schema:DefinedTerm
152 Na1d66e63073a4e509b8a9bcce6e3ce2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Female
154 rdf:type schema:DefinedTerm
155 Na97730f8904247c0b23d1a7d07199786 rdf:first sg:person.01145574514.32
156 rdf:rest Nbfdc6c1217e24613a04245be4fdd3f5e
157 Nb1839207a51140f3964356a0584b557c rdf:first sg:person.013547252522.01
158 rdf:rest Na97730f8904247c0b23d1a7d07199786
159 Nb54dfd2cf0374969bdaab01afa0214dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Receptors, IgG
161 rdf:type schema:DefinedTerm
162 Nb7a6e33336b14aaca649e5097712d714 rdf:first sg:person.01031346114.94
163 rdf:rest Nb1839207a51140f3964356a0584b557c
164 Nbb70f4d545f948fc865ef3cfae5ddb4c rdf:first sg:person.012611662635.04
165 rdf:rest N8617ac9b5d7f47e29b5a45c880695f9f
166 Nbca9cc45122543188e9c8371aaffc584 rdf:first sg:person.0604532214.34
167 rdf:rest Nd09e3b808f8a4c38a12416bfc1eaf104
168 Nbfdc6c1217e24613a04245be4fdd3f5e rdf:first sg:person.01213707714.59
169 rdf:rest Nbb70f4d545f948fc865ef3cfae5ddb4c
170 Nc747106c04584978b978c8ad868fb7f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Genotype
172 rdf:type schema:DefinedTerm
173 Nd09e3b808f8a4c38a12416bfc1eaf104 rdf:first sg:person.0731431552.48
174 rdf:rest N22f912c1b41643ca81a5aebc4e5b3131
175 Nd1757fe53dc445d2a91637d876fa8e6e schema:name pubmed_id
176 schema:value 23358932
177 rdf:type schema:PropertyValue
178 Ne65c61f86c6b4275a7fe1887501e6045 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Adult
180 rdf:type schema:DefinedTerm
181 Nf0d14dac81754a17abd30add774fd1df schema:volumeNumber 65
182 rdf:type schema:PublicationVolume
183 Nf752af49ca8143cea725516b8e6cc57a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Polymorphism, Single Nucleotide
185 rdf:type schema:DefinedTerm
186 Nff39ff9872b2432c8079a812b684ba9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Anti-Inflammatory Agents, Non-Steroidal
188 rdf:type schema:DefinedTerm
189 Nff42b2d8a7f544f48fb90d999ab1e9a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Antibodies, Monoclonal
191 rdf:type schema:DefinedTerm
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
196 schema:name Immunology
197 rdf:type schema:DefinedTerm
198 sg:grant.6075693 http://pending.schema.org/fundedItem sg:pub.10.1007/s00251-013-0679-8
199 rdf:type schema:MonetaryGrant
200 sg:journal.1019755 schema:issn 0093-7711
201 1432-1211
202 schema:name Immunogenetics
203 schema:publisher Springer Nature
204 rdf:type schema:Periodical
205 sg:person.01001764110.70 schema:affiliation grid-institutes:grid.69566.3a
206 schema:familyName Kuroha
207 schema:givenName Masatake
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001764110.70
209 rdf:type schema:Person
210 sg:person.01031346114.94 schema:affiliation grid-institutes:None
211 schema:familyName Moroi
212 schema:givenName Rintaro
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031346114.94
214 rdf:type schema:Person
215 sg:person.01145574514.32 schema:affiliation grid-institutes:grid.69566.3a
216 schema:familyName Kinouchi
217 schema:givenName Yoshitaka
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145574514.32
219 rdf:type schema:Person
220 sg:person.01213707714.59 schema:affiliation grid-institutes:grid.69566.3a
221 schema:familyName Shiga
222 schema:givenName Hisashi
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213707714.59
224 rdf:type schema:Person
225 sg:person.01255535707.76 schema:affiliation grid-institutes:grid.69566.3a
226 schema:familyName Shimosegawa
227 schema:givenName Tooru
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255535707.76
229 rdf:type schema:Person
230 sg:person.01256304453.19 schema:affiliation grid-institutes:grid.177174.3
231 schema:familyName Horiuchi
232 schema:givenName Takahiko
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256304453.19
234 rdf:type schema:Person
235 sg:person.012611662635.04 schema:affiliation grid-institutes:grid.69566.3a
236 schema:familyName Kakuta
237 schema:givenName Yoichi
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012611662635.04
239 rdf:type schema:Person
240 sg:person.01304671035.37 schema:affiliation grid-institutes:grid.69566.3a
241 schema:familyName Takahashi
242 schema:givenName Seiichi
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304671035.37
244 rdf:type schema:Person
245 sg:person.013547252522.01 schema:affiliation grid-institutes:grid.69566.3a
246 schema:familyName Endo
247 schema:givenName Katsuya
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013547252522.01
249 rdf:type schema:Person
250 sg:person.0604532214.34 schema:affiliation grid-institutes:grid.69566.3a
251 schema:familyName Kanazawa
252 schema:givenName Yoshitake
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604532214.34
254 rdf:type schema:Person
255 sg:person.0731431552.48 schema:affiliation grid-institutes:grid.69566.3a
256 schema:familyName Shimodaira
257 schema:givenName Yosuke
258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731431552.48
259 rdf:type schema:Person
260 sg:pub.10.1038/74704 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000366392
261 https://doi.org/10.1038/74704
262 rdf:type schema:CreativeWork
263 grid-institutes:None schema:alternateName 1-1, Seiryo, Aoba-ku, Sendai, Miyagi, Japan
264 schema:name 1-1, Seiryo, Aoba-ku, Sendai, Miyagi, Japan
265 Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan
266 rdf:type schema:Organization
267 grid-institutes:grid.177174.3 schema:alternateName Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Kyushu, Japan
268 schema:name Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Kyushu, Japan
269 rdf:type schema:Organization
270 grid-institutes:grid.69566.3a schema:alternateName Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan
271 schema:name Division of Gastroenterology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan
272 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...